Breaking News Instant updates and real-time market news.

ABT

Abbott

$76.23

-1.27 (-1.64%)

09:08
04/17/19
04/17
09:08
04/17/19
09:08

Abbott says 'right on track' with FY expectations

Comments taken from the Q1 earnings conference call.

  • 17

    Apr

  • 26

    Apr

  • 30

    Apr

  • 06

    May

  • 08

    May

ABT Abbott
$76.23

-1.27 (-1.64%)

03/22/19
BMOC
03/22/19
NO CHANGE
Target $204
BMOC
Outperform
Edwards Lifesciences price target raised to $204 from $190 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Edwards Lifesciences (EW) to $204 and kept her Outperform rating while removing the stock from her Top Picks list after its 25% year-to-date run-up. While there are some mid-year catalysts for the company such as the outcomes from the CMS NationalCoverage Decision proposal on March 27, clinical data from Pascal, and patent litigation with Abbott (ABT) regarding Pascal, the analyst contends that some consolidation in the stock price would not be surprising.
03/26/19
PIPR
03/26/19
NO CHANGE
Target $165
PIPR
Overweight
Piper discusses 16% selloff in DexCom over past three trading days
Piper Jaffray analyst JP McKim says he's fielded a lot of investor questions with shares of DexCom (DXCM) down 16% over the last three trading days. The crux of the selloff is Abbott's (ABT) Libre 2.0 and whether it gets interoperable continuous glucose monitoring and if so, what that does to volumes and price, McKim tells investors in a research note. The analyst sees little risk to DexCom's volumes for given the market inflection for continuous glucose monitoring, but adds that if Libre gets iCGM "payers maybe push a little harder on price." McKim admits that "headline risk is building around the approval" but keeps an Overweight rating on DexCom shares with a $165 price target. Libre 2.0 getting iCGM is not fully priced in the stock at this point, but some of that risk certainly is, says McKim.
04/03/19
JPMS
04/03/19
NO CHANGE
Target $175
JPMS
Overweight
JPMorgan remains 'very bullish' on DexCom despite Libre 2.0 uncertainty
The latest DexCom (DXCM) controversy is "whirling speculation" around Abbott's (ABT) Libre 2.0 launch, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst keeps an Overweight rating on DexCom shares with a $175 price target but expects uncertainty over Libre 2.0 to remain an overhang until it receives U.S. approval. However, he remains "very bullish" on the shares and sees "significant upside" to 2019 estimates. DexComis the best positioned in diabetes longer-term, Marcus contends.
04/15/19
RBCM
04/15/19
NO CHANGE
Target $82
RBCM
Sector Perform
Abbott price target raised to $82 from $77 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Abbott to $82 ahead of its Q1 results, saying the "pattern of revenue growth" seen last year should continue this quarter as Core Laboratory, Electrophysiology, Structural Heart, and Diabetes Care product categories "lead the way." The analyst also expects Abbott's organic revenue growth in the Medical Devices segment to come at the high end of guidance, adding that while his new price target implies a multiple of 22.5-times vs. peer group's 21-times, he believes that the company's growth profile justifies the valuation premium. Henry recommends that investors buy the stock on "any weakness".

TODAY'S FREE FLY STORIES

ENB

Enbridge

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Enbridge rating change  »

Enbridge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

GBNXF

Gibson Energy

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Gibson Energy rating change  »

Gibson Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAD

Lithia Motors

$104.90

7.19 (7.36%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Upgrade
Lithia Motors rating change  »

Stephens upgrades Lithia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    May

  • 13

    Nov

BBU

Brookfield Business Partners

$37.80

-0.17 (-0.45%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Hot Stocks
Brookfield Business Partners selling BGRS for $230M in proceeds »

Brookfield Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:44
04/25/19
04/25
06:44
04/25/19
06:44
Earnings
CBIZ backs FY19 EPS view up 10%-12%, consensus $1.20 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

NGD

New Gold

$0.88

0.0253 (2.96%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
New Gold reports Q1 adjusted EPS 0c, consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

MTSI

Macom

$15.86

-0.33 (-2.04%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
CBIZ reports Q1 EPS 67c, consensus 70c »

Reports Q1 revenue $270M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

BIP

Brookfield Infrastructure

$41.62

-0.03 (-0.07%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Brookfield Infrastructure rating change  »

Brookfield Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

WYNN

Wynn Resorts

$144.35

1.35 (0.94%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Upgrade
Wynn Resorts rating change  »

Wynn Resorts upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ALXN

Alexion

$130.12

-2.24 (-1.69%)

06:41
04/25/19
04/25
06:41
04/25/19
06:41
Earnings
Alexion raises FY19 adj. EPS view to $9.25-$9.45 from $9.10-$9.30 »

FY19 consensus $9.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    Jun

LUV

Southwest

$52.92

0.11 (0.21%)

06:40
04/25/19
04/25
06:40
04/25/19
06:40
Earnings
Southwest reports Q1 EPS 70c, consensus 61c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 13

    Nov

MMM

3M

$219.24

-0.28 (-0.13%)

06:39
04/25/19
04/25
06:39
04/25/19
06:39
Hot Stocks
Breaking Hot Stocks news story on 3M »

3M drops 6% to $205.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

EQT

EQT Corporation

$20.75

-0.26 (-1.24%)

06:39
04/25/19
04/25
06:39
04/25/19
06:39
Earnings
EQT Corporation reports Q1 adjusted EPS 83c, consensus 74c »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ALXN

Alexion

$130.12

-2.24 (-1.69%)

06:38
04/25/19
04/25
06:38
04/25/19
06:38
Earnings
Alexion reports Q1 adjusted EPS $2.39, consensus $2.19 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    Jun

BWA

BorgWarner

$43.50

-0.135 (-0.31%)

06:38
04/25/19
04/25
06:38
04/25/19
06:38
Earnings
BorgWarner backs FY19 EPS view $4.00-$4.35, consensus $4.20 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SSNLF

Samsung

$0.00

(0.00%)

, BTC

Bitcoin

$0.00

(0.00%)

06:37
04/25/19
04/25
06:37
04/25/19
06:37
Periodicals
Samsung plans to develop its own Ethereum-based blockchain, token, TNW reports »

Samsung is planning to…

SSNLF

Samsung

$0.00

(0.00%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$87.75

-2.53 (-2.80%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Hot Stocks
Valero says expects to invests about $2.5B of capital in 2019, 2020 »

The Houston alkylation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

BWA

BorgWarner

$43.50

-0.135 (-0.31%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Earnings
BorgWarner sees Q2 adj. EPS 99c-$1.05, consensus $1.07 »

Sees Q2 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

VLO

Valero

$87.75

-2.53 (-2.80%)

06:36
04/25/19
04/25
06:36
04/25/19
06:36
Earnings
Valero reports Q1 EPS 34c, consensus 29c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

XRX

Xerox

$33.68

-0.53 (-1.55%)

06:35
04/25/19
04/25
06:35
04/25/19
06:35
Earnings
Xerox raises 2019 adjusted EPS view to $3.80-$3.95 from $3.70-$3.80 »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

MMM

3M

$219.24

-0.28 (-0.13%)

06:35
04/25/19
04/25
06:35
04/25/19
06:35
Hot Stocks
3M CEO says 'the first quarter was a disappointing start to the year' »

"The first quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

MMM

3M

$219.24

-0.28 (-0.13%)

06:34
04/25/19
04/25
06:34
04/25/19
06:34
Hot Stocks
3M sees FY19 organic local-currency sales growth (1%)-2% »

"3M also updated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

XRX

Xerox

$33.68

-0.53 (-1.55%)

06:34
04/25/19
04/25
06:34
04/25/19
06:34
Earnings
Xerox reports Q1 adjusted EPS 91c, consensus 78c »

Reports Q1 revenue $2.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

BWA

BorgWarner

$43.50

-0.135 (-0.31%)

06:34
04/25/19
04/25
06:34
04/25/19
06:34
Earnings
BorgWarner reports Q1 adj. EPS $1.00, consensus 95c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.